Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060345740> ?p ?o ?g. }
- W2060345740 endingPage "1289" @default.
- W2060345740 startingPage "1279" @default.
- W2060345740 abstract "The ability of the alpha 2-agonists clonidine, B-HT920 (6-allyl-2-amino-5,6,7,8-tetrohydro-4H-thiazolo-[4,5-d]-azepine) and guanfacine to improve memory in aged monkeys has been related to their affinity to bind at a proposed rauwolscine-insensitive (Ri) subtype of alpha 2-adrenergic receptor, while their hypotensive and sedating effects have been related to affinity at a rauwolscine-sensitive site (Rs) (Arnsten et al., 1988). The present study examined the alpha 2-agonist UK-14304 (5-bromo-6 [2-imidazoline-2-yl amino] quinoxaline) for its binding characteristics in tissue from the brain of the rat and for its behavioral effects in aged monkeys. The drug UK-14304 was found to have slightly higher affinity for the Ri than the Rs site (Ki values of 138 and 245 nM, respectively), but was not as selective as the alpha 2-agonist guanfacine (Ki values of 23 and 340 nM, respectively). Consistent with this binding profile, very small doses of UK-14304 (0.00017-0.17 micrograms/kg) produced a reliable but modest improvement in memory in the aged monkeys (average improvement of 16.7% +/- 2.6% following an optimal dose). No hypotensive or sedating side effects were observed at these small doses. However, hypotension and sedation emerged rapidly when the dose was raised above 1.7 micrograms/kg and at the largest doses tested (50.0-100.0 micrograms/kg), hypotension was severe (systolic pressure below 70 mm Hg) and the animals were too sedated to complete cognitive testing. The separation between doses that improved memory and those that produced hypotension and sedation was not as great for UK-14304 as it was for guanfacine, consistent with the greater selectivity of guanfacine for the Ri site. These results offer a fourth example whereby the ability of an alpha 2-agonist to improve cognitive function, without side effects, could be related to the relative affinities for the Ri and Rs sites." @default.
- W2060345740 created "2016-06-24" @default.
- W2060345740 creator A5019453928 @default.
- W2060345740 creator A5088026484 @default.
- W2060345740 date "1991-12-01" @default.
- W2060345740 modified "2023-10-16" @default.
- W2060345740 title "Behavioral and receptor binding analysis of the α2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-YL amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an α2-adrenoceptor subtype" @default.
- W2060345740 cites W130740266 @default.
- W2060345740 cites W1545336881 @default.
- W2060345740 cites W1550411069 @default.
- W2060345740 cites W1555121428 @default.
- W2060345740 cites W1986908849 @default.
- W2060345740 cites W1995391009 @default.
- W2060345740 cites W1996645695 @default.
- W2060345740 cites W2000247756 @default.
- W2060345740 cites W2006913937 @default.
- W2060345740 cites W2007742009 @default.
- W2060345740 cites W2009615669 @default.
- W2060345740 cites W2012335673 @default.
- W2060345740 cites W2014321807 @default.
- W2060345740 cites W2016109861 @default.
- W2060345740 cites W2029643412 @default.
- W2060345740 cites W2033273782 @default.
- W2060345740 cites W2033720653 @default.
- W2060345740 cites W2044909621 @default.
- W2060345740 cites W2048712633 @default.
- W2060345740 cites W2052325698 @default.
- W2060345740 cites W2055912815 @default.
- W2060345740 cites W2065393074 @default.
- W2060345740 cites W2067292897 @default.
- W2060345740 cites W2073212068 @default.
- W2060345740 cites W2074631079 @default.
- W2060345740 cites W2079208046 @default.
- W2060345740 cites W2086479682 @default.
- W2060345740 cites W2091322168 @default.
- W2060345740 cites W2095527991 @default.
- W2060345740 cites W2107109924 @default.
- W2060345740 cites W2147123664 @default.
- W2060345740 doi "https://doi.org/10.1016/0028-3908(91)90024-6" @default.
- W2060345740 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1686301" @default.
- W2060345740 hasPublicationYear "1991" @default.
- W2060345740 type Work @default.
- W2060345740 sameAs 2060345740 @default.
- W2060345740 citedByCount "63" @default.
- W2060345740 countsByYear W20603457402014 @default.
- W2060345740 countsByYear W20603457402015 @default.
- W2060345740 countsByYear W20603457402016 @default.
- W2060345740 countsByYear W20603457402017 @default.
- W2060345740 countsByYear W20603457402018 @default.
- W2060345740 countsByYear W20603457402020 @default.
- W2060345740 countsByYear W20603457402023 @default.
- W2060345740 crossrefType "journal-article" @default.
- W2060345740 hasAuthorship W2060345740A5019453928 @default.
- W2060345740 hasAuthorship W2060345740A5088026484 @default.
- W2060345740 hasConcept C123605464 @default.
- W2060345740 hasConcept C126322002 @default.
- W2060345740 hasConcept C13348194 @default.
- W2060345740 hasConcept C134018914 @default.
- W2060345740 hasConcept C138496976 @default.
- W2060345740 hasConcept C15744967 @default.
- W2060345740 hasConcept C158453852 @default.
- W2060345740 hasConcept C170493617 @default.
- W2060345740 hasConcept C171606756 @default.
- W2060345740 hasConcept C185592680 @default.
- W2060345740 hasConcept C2776504411 @default.
- W2060345740 hasConcept C2776885963 @default.
- W2060345740 hasConcept C2777676773 @default.
- W2060345740 hasConcept C2778399450 @default.
- W2060345740 hasConcept C2778938600 @default.
- W2060345740 hasConcept C2780815205 @default.
- W2060345740 hasConcept C40465926 @default.
- W2060345740 hasConcept C49453240 @default.
- W2060345740 hasConcept C55493867 @default.
- W2060345740 hasConcept C58732023 @default.
- W2060345740 hasConcept C64943373 @default.
- W2060345740 hasConcept C71924100 @default.
- W2060345740 hasConcept C98274493 @default.
- W2060345740 hasConceptScore W2060345740C123605464 @default.
- W2060345740 hasConceptScore W2060345740C126322002 @default.
- W2060345740 hasConceptScore W2060345740C13348194 @default.
- W2060345740 hasConceptScore W2060345740C134018914 @default.
- W2060345740 hasConceptScore W2060345740C138496976 @default.
- W2060345740 hasConceptScore W2060345740C15744967 @default.
- W2060345740 hasConceptScore W2060345740C158453852 @default.
- W2060345740 hasConceptScore W2060345740C170493617 @default.
- W2060345740 hasConceptScore W2060345740C171606756 @default.
- W2060345740 hasConceptScore W2060345740C185592680 @default.
- W2060345740 hasConceptScore W2060345740C2776504411 @default.
- W2060345740 hasConceptScore W2060345740C2776885963 @default.
- W2060345740 hasConceptScore W2060345740C2777676773 @default.
- W2060345740 hasConceptScore W2060345740C2778399450 @default.
- W2060345740 hasConceptScore W2060345740C2778938600 @default.
- W2060345740 hasConceptScore W2060345740C2780815205 @default.
- W2060345740 hasConceptScore W2060345740C40465926 @default.
- W2060345740 hasConceptScore W2060345740C49453240 @default.
- W2060345740 hasConceptScore W2060345740C55493867 @default.
- W2060345740 hasConceptScore W2060345740C58732023 @default.
- W2060345740 hasConceptScore W2060345740C64943373 @default.